Entellus Medical (ENTL)Posts Q3 Loss of 32c/Share; Updates FY15 Outlook

Entellus Medical (NASDAQ: ENTL) reported Q3 EPS of $0.32, versus the analyst estimate of ($0.25). Revenue for the quarter came in at $14.8 million versus the consensus estimate of $14.19 million.

Entellus Medical sees FY2015 EPS of ($1.12)-($0.99), versus the consensus of ($0.92). Entellus Medical sees FY2015 revenue of $605-61.5 million, versus the consensus of $60.4 million.

For earnings history and earnings-related data on Entellus Medical (ENTL) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Beyond Air, Inc. (XAIR) Tops Q1 reported Q1 Revenue ; Offers Guidance
• Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 4c ; Offers Guidance